GB Sciences, Inc.
GBLX · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,362 | -$4,125 | -$915 | -$4,117 |
| Dep. & Amort. | $1 | $62 | $70 | $47 |
| Deferred Tax | $0 | $20,195,000 | $0 | $581 |
| Stock-Based Comp. | $219 | $17 | $61 | $436 |
| Change in WC | $403 | $85 | $69 | -$271 |
| Other Non-Cash | -$237 | -$20,192,566 | -$1,151 | $1,138 |
| Operating Cash Flow | -$976 | -$1,527 | -$1,866 | -$2,185 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$32 | -$200 | -$293 |
| Net Acquisitions | $0 | $0 | $1,649 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $320 | $0 | $2 | $4,948 |
| Investing Cash Flow | $320 | -$32 | $1,450 | $4,656 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $322 | -$49 | -$525 | -$2,283 |
| Stock Issued | $236 | $1,483 | $139 | $1,075 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$110 | -$269 |
| Financing Cash Flow | $558 | $1,435 | -$496 | -$1,476 |
| Forex Effect | $0 | $0 | $0 | -$353 |
| Net Chg. in Cash | -$98 | -$124 | -$912 | $641 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $110 | $234 | $1,146 | $152 |
| End Cash | $12 | $110 | $234 | $793 |
| Free Cash Flow | -$976 | -$1,559 | -$2,066 | -$2,478 |